Pedro Henrique Rodrigues Da Silva

Dr. Pedro Henrique Rodrigues Da Silva

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
BPBianca Silva Pinto
Bianca Silva Pinto
BCBeatriz Araújo Cavendish
Beatriz Araújo Cavendish
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
PSPaulo Suen
Paulo Suen
KMKalian Almeida Pereira Marinho
Kalian Almeida Pereira Marinho
LRLais Razza
Lais Razza
Transcranial direct current stimulation (tDCS) has been showing promising effects for the treatment of obsessive–compulsive disorder (OCD), but there is still no conclusion on its efficacy for this disorder. We performed a systematic review and meta-analysis of trials using tDCS for OCD and a computer modeling analysis to evaluate the electric field (EF) strengths of different electrode assemblies in brain regions of interest (ROIs) (PROSPERO-42021262465). PubMed/MEDLINE, Embase, Cochrane Library and Web of Science databases were searched from inception to 25 September 2022. Randomized controlled trials (RCTs) and open-label studies were included. The primary aim was the effect size (Hedges’ g) of continuous outcomes and potential moderators of response. For EF modeling, SimNIBS software was used. Four RCTs and four open-label trials were included (n = 241). Results revealed a large effect of tDCS in the endpoint, but no significant effect between active and sham protocols. No predictor of response was found. EF analysis revealed that montages using the main electrode over the (pre)supplementary motor area with an extracephalic reference electrode might lead to stronger EFs in the predefined ROIs. Our results revealed that tDCS might be a promising intervention to treat OCD; however, larger studies are warranted.

19 March 2021 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
KDKarolyne Dell Ducas
Karolyne Dell Ducas
AFAntonio Carlos da S. Senra Filho
Antonio Carlos da S. Senra Filho
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
KSKaio Felippe Secchinato
Kaio Felippe Secchinato
Renata F LeoniRenata F Leoni
Renata F Leoni
ASANTONIO CARLOS DOS SANTOS
ANTONIO CARLOS DOS SANTOS

5 June 2023 in Brain Topography
Verified
Journal Article
Closed access
PDF file
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
FLFrank-Erik de Leeuw
Frank-Erik de Leeuw
MZMaria Clara Zanon Zotin
Maria Clara Zanon Zotin
ONOctavio Marques Pontes Neto
Octavio Marques Pontes Neto
RLRenata Ferranti Leoni
Renata Ferranti Leoni
ATAnil M Tuladhar
Anil M Tuladhar

5 June 2024 in Brain Topography
Verified
Journal Article
Closed access
PDF file
IAIsabella Velloso Arrigo
Isabella Velloso Arrigo
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
Renata F LeoniRenata F Leoni
Renata F Leoni

27 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
LRLais Razza
Lais Razza
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
GBGeraldo F. Busatto
Geraldo F. Busatto
FDFábio Luis de Souza Duran
Fábio Luis de Souza Duran
JPJuliana Pereira
Juliana Pereira
ABAndre R. Brunoni
Andre R. Brunoni
Non-invasive brain stimulation (NIBS) interventions are promising for the treatment of psychiatric disorders. Notwithstanding, the NIBS mechanisms of action over the dorsolateral prefrontal cortex (DLPFC), a hub that modulates affective and cognitive processes, have not been completely mapped. We aimed to investigate regional cerebral blood flow (rCBF) changes over the DLPFC and the subgenual anterior cingulate cortex (sgACC) of different NIBS protocols using Single-Photon Emission Computed Tomography (SPECT). A factorial, within-subjects, double-blinded study was performed. Twenty-three healthy subjects randomly underwent four sessions of NIBS applied once a week: transcranial direct current stimulation (tDCS), intermittent theta-burst stimulation (iTBS), combined tDCS + iTBS and placebo. The radiotracer 99m-Technetium-ethylene-cysteine-dimer was injected intravenously during the NIBS session, and SPECT neuroimages were acquired after the session. Results revealed that the combination of tDCS + iTBS increased right sgACC rCBF. Cathodal and anodal tDCS increased and decreased DLPFC rCBF, respectively, while iTBS showed no significant changes compared to the placebo. Our findings suggest that the combined protocol might optimize the activity in the right sgACC and encourage future trials with neuropsychiatric populations. Moreover, mechanistic studies to investigate the effects of tDCS and iTBS over the DLPFC are required.

30 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
HBHelena Bellini
Helena Bellini
ECEric Cretaz
Eric Cretaz
ACADRIANA Munhoz Carneiro
ADRIANA Munhoz Carneiro
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
LSLeonardo Afonso dos Santos
Leonardo Afonso dos Santos
ABAndre R. Brunoni
Andre R. Brunoni
Treatment-resistant depression (TRD), characterized by the failure to achieve symptomatic remission despite multiple pharmacotherapeutic treatments, poses a significant challenge for clinicians. Electroconvulsive therapy (ECT) is an effective but limited option due to its cognitive side effects. In this context, magnetic seizure therapy (MST) has emerged as a promising alternative, offering comparable antidepressant efficacy with better cognitive outcomes. However, the clinical outcomes and cognitive effects of MST require further investigation. This double-blinded, randomized, non-inferiority study aims to compare the efficacy, tolerability, cognitive adverse effects, and neurophysiological biomarkers of MST with bilateral ECT (BT ECT) in patients with TRD. This study will employ multimodal nuclear magnetic resonance imaging (MRI) and serum neurotrophic markers to gain insight into the neurobiological basis of seizure therapy. Additionally, neurophysiological biomarkers will be evaluated as secondary outcomes to predict the antidepressant and cognitive effects of both techniques. The study design, recruitment methods, ethical considerations, eligibility criteria, interventions, and blinding procedures are described. The expected outcomes will advance the field by offering a potential alternative to ECT with improved cognitive outcomes and a better understanding of the underlying pathophysiology of depression and antidepressant therapies.